Brown Miller Wealth Management LLC Grows Stock Position in The Clorox Company $CLX

Brown Miller Wealth Management LLC increased its holdings in The Clorox Company (NYSE:CLX) by 18.9% in the 2nd quarter, according to its most recent disclosure with the SEC. The firm owned 3,225 shares of the company’s stock after acquiring an additional 513 shares during the period. Brown Miller Wealth Management LLC’s holdings in Clorox were worth $387,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Raymond James Financial Inc. raised its holdings in Clorox by 15.6% in the 1st quarter. Raymond James Financial Inc. now owns 269,926 shares of the company’s stock valued at $39,747,000 after buying an additional 36,352 shares during the period. OneDigital Investment Advisors LLC acquired a new stake in shares of Clorox during the first quarter valued at about $247,000. Roman Butler Fullerton & Co. purchased a new stake in shares of Clorox in the 1st quarter valued at approximately $400,000. Wedge Capital Management L L P NC boosted its position in shares of Clorox by 33.5% during the 1st quarter. Wedge Capital Management L L P NC now owns 28,510 shares of the company’s stock worth $4,198,000 after purchasing an additional 7,159 shares during the period. Finally, Cornerstone Wealth Group LLC boosted its position in shares of Clorox by 19.0% during the 1st quarter. Cornerstone Wealth Group LLC now owns 25,582 shares of the company’s stock worth $3,767,000 after purchasing an additional 4,085 shares during the period. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have commented on CLX shares. Barclays decreased their price target on Clorox from $118.00 to $112.00 and set an “underweight” rating on the stock in a research note on Tuesday, September 30th. Citigroup reissued a “neutral” rating and set a $135.00 target price (down previously from $140.00) on shares of Clorox in a research note on Tuesday, July 15th. Jefferies Financial Group dropped their target price on Clorox from $167.00 to $145.00 and set a “buy” rating for the company in a research report on Thursday, June 26th. TD Cowen cut their price target on shares of Clorox from $120.00 to $117.00 and set a “hold” rating on the stock in a research note on Wednesday. Finally, The Goldman Sachs Group lowered their price objective on shares of Clorox from $115.00 to $110.00 and set a “sell” rating for the company in a research note on Wednesday. One equities research analyst has rated the stock with a Buy rating, ten have given a Hold rating and three have given a Sell rating to the company. According to MarketBeat, Clorox currently has an average rating of “Reduce” and an average target price of $134.08.

Insider Transactions at Clorox

In other news, COO Eric H. Reynolds sold 15,041 shares of the company’s stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the completion of the transaction, the chief operating officer directly owned 54,221 shares of the company’s stock, valued at approximately $6,711,475.38. This represents a 21.72% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.57% of the stock is owned by company insiders.

Clorox Stock Performance

Shares of CLX opened at $123.30 on Friday. The Clorox Company has a 1 year low of $116.53 and a 1 year high of $171.37. The stock has a market capitalization of $15.08 billion, a PE ratio of 18.91, a PEG ratio of 0.99 and a beta of 0.52. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84. The stock has a 50-day simple moving average of $122.81 and a 200-day simple moving average of $129.53.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Thursday, July 31st. The company reported $2.87 EPS for the quarter, topping the consensus estimate of $2.24 by $0.63. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The company had revenue of $1.99 billion during the quarter, compared to analysts’ expectations of $1.94 billion. During the same quarter in the previous year, the business posted $1.82 EPS. The firm’s revenue was up 4.5% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. On average, analysts predict that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, November 6th. Shareholders of record on Wednesday, October 22nd will be paid a $1.24 dividend. The ex-dividend date is Wednesday, October 22nd. This represents a $4.96 dividend on an annualized basis and a yield of 4.0%. Clorox’s dividend payout ratio (DPR) is currently 76.07%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.